QUALITY OF LIFE IN PATIENTS WITH HYPERTENSION, CORONARY HEART DISEASE, AND ATHEROSCLEROTIC LESION OF LOWER EXTREMITY ARTERIES IN THE SECONDARY PREVENTION OF COMPLICATIONS
https://doi.org/10.17650/1818-8338-2013-7-2-180-197
Abstract
Atherosclerotic lesion of lower extremity arteries frequently complicates the long-term course of hypertension and it is generally associated with coronary heart disease. Our study has attempted to evaluate the impact of combination antihypertensive therapy involving amlodipine, bisoprolol, and lisinopril on quality of life in this category of patients.
About the Authors
A. A. Karlov
Russian Medical Academy of Postgraduate Education, Ministry of Health of Russia
Russian Federation
Department of Cardiology
Russian Federation
Department of Cardiology
N. A. Karlova
Russian Medical Academy of Postgraduate Education, Ministry of Health of Russia
Russian Federation
Department of Cardiology
Russian Federation
Department of Cardiology
E. A. Zolozova
Russian Medical Academy of Postgraduate Education, Ministry of Health of Russia
Russian Federation
Department of Cardiology
Russian Federation
Department of Cardiology
E. V. Sayutina
Russian Medical Academy of Postgraduate Education, Ministry of Health of Russia
Russian Federation
Department of Cardiology
Russian Federation
Department of Cardiology
V. V. Chigineva
Russian Medical Academy of Postgraduate Education, Ministry of Health of Russia
Russian Federation
Department of Cardiology
Russian Federation
Department of Cardiology
References
1. Бузиашвили Ю.И. Диагностика и лечение мультифокального атеросклероза. В кн.: Лекции по кардиологии. Под ред. Л.А. Бокерия, Е.З. Голуховой. М.: Изд-во НЦССХ им. А.Н. Бакулева РАМН, 2001. T. 2. С. 142–61.
2. ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of
3. the European Society of Cardiology (ESC). Eur Heart J 2011;32(22):2851–906.
4. Nehler M.R., McDermott M.M., Treat-Jacobson D. et al. Functional outcomes and quality of Life in peripheral arterial disease: current status. Vasc Med 2003;8(2):115–26.
5. Hiatt W.R., Nawaz D., Regensteiner J.G., Hossack K.F. The evaluation of exercise performance in patients with peripheral vascular disease. J Cardiopulmonary Rehabil 1988;12:525–32.
6. Nicolaï S.P., Kruidenier L.M., Rouwet E.V. et al. The walking impairment questionnaire: An effective tool to assess the effect of treatment in patients with intermittent claudication. J Vasc Surg
7. ;50(1):89–94.
8. Ikeda S., Kobayashi M., Shigematsu H. et al. Development of the Japanese Version of Walking Impairment Questionnaire (WIQ). J Jpn Coll Angiol 2005;45(4):233–40.
9. Collins T.C., Suarez-Almazor M., Petersen N.J., O'Malley K.J. A Spanish translation of the Walking Impairment Questionnaire was validated for patients with peripheral arterial disease. J Clin Epidemiol
10. ;57(12):1305–15.
11. Jie Wang, Yan Cui, Bian R.W. et al. Validation of the Chinese version of the Walking Impairment
12. Questionnaire in patients with both peripheral arterial disease and type 2 diabetes mellitus. Diab Vasc Dis Res 2011;8(1):29–34.
13. Hiatt W.R., Regensteiner J.G., Creager M.A. et al. Propionyl-L-carnitine improves exercise performance and functional status in patients with claudication. Am J Med 2001;110(8):616–22.
14. Рогоза А.Н., Балахонова Т.В., Чихладзе Н.М. Методы определения лодыжечно-плечевого индекса систолического давления при массовых обследованиях. Consilium Medicum 2009;11(10):66–71.
15. Regensteiner J.G., Steiner J.F., Hiatt W.R. Exercise training improves functional status in patients with peripheral arterial disease. J Vasc Surg 1996;23(1):104–15.
16. Dilie M., Mlaco A., Helji- B. et al. Arterial hypertension as a risk factor multifocal atherosclerosis. Med Arh 2002;56(2):93–6.
17. Pitt B., Byngton R.P., Furberg C.D. et al. Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events. PREVENT Investigators. Circulation 2000;102(3):1503–10.
18. Rana R., Patil A. Efficacy and safety of bisoprolol plus amlodipine fixed dose combination in essential hypertension. The Indian Practitioner 2008; 61(4):225–34.
19. Black H.R., Davis B., Barzilay J. et al. Metabolic and clinical outcomes in nondiabetic individuals with the metabolic syndrome assigned to chlorthalidone, amlodipine, or lisinopril as initial treatment for
20. hypertension: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Diabetes Care 2008;31(2):353–60.
21. Brilla C.G., Funck R.C., Rupp H. Lisinoprilmediated regression of myocardial fibrosis in patients with hypertensive heart disease. Circulation 2000;102(12):1388–93.
22. Агеев Ф.Т., Смирнова М.Д., Фофанова Т.В. Повышение приверженности к терапии: «дело техники»? Сердечн недостат 2011;12(4):238–43.
23. Benson J., Britten N. Patients' views about taking antihypertensive drugs: questionnaire study. BMJ 2003;326:1314–5.
Review
For citations:
Karlov A.A., Karlova N.A., Zolozova E.A., Sayutina E.V., Chigineva V.V. QUALITY OF LIFE IN PATIENTS WITH HYPERTENSION, CORONARY HEART DISEASE, AND ATHEROSCLEROTIC LESION OF LOWER EXTREMITY ARTERIES IN THE SECONDARY PREVENTION OF COMPLICATIONS. The Clinician. 2013;7(2):34-39. (In Russ.) https://doi.org/10.17650/1818-8338-2013-7-2-180-197
Views:
859
Email this article 